Central Nervous System Targeted Protein Degraders

Diseases of the central nervous system, which once occupied a large component of the pharmaceutical industry research and development portfolio, have for many years played a smaller part in major pharma pipelines—primarily due to the well cited challenges in target validation, valid translational mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Bedwyr ab Ion, Lewis, H. Lois, Jones, D. Heulyn, Ward, Simon E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452695/
https://www.ncbi.nlm.nih.gov/pubmed/37627229
http://dx.doi.org/10.3390/biom13081164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452695/
https://www.ncbi.nlm.nih.gov/pubmed/37627229
http://dx.doi.org/10.3390/biom13081164

Ejemplares similares